Skip to the page

Data / Form D filings / Glycotest Inc.

Glycotest Inc.: Form D filing

Glycotest Inc., a health care company in Merion Station, PA, filed a Form D with the SEC in 2026. The latest, on July 16, 2026, reports $3.2 million sold of a $6.8 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
613 SCHILLER AVE., Merion Station, PA, 19066
Phone
(484) 431-3483
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2144866

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 16, 2026New notice$6,798,345$3,220,105$3,578,2403Jun 30, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Charles SwindellExecutive Officer, Director
Ilian IlievDirector
Ed HooperDirector
Jenny JiangDirector

Other health care companies in Pennsylvania that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in Pennsylvania · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Glycotest Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.